Rosa Metella Refini

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.

Piersante Sestini, L Armetti, G. Gambaro et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 256 citations

Asthma, Micrograms Pge2, Prostaglandin Synthesis +16

Protective Effect of Inhaled Furosemide on Allergen-Induced Early and Late Asthmatic Reactions

S. Bianco, Maria Pieroni, Rosa Metella Refini et al. · New England Journal of Medicine · 1989 · 221 citations

Asthma, Allergy Medicine, Placebo Administration +16

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial

Patrizio Vitulo, Anna Agnese Stanziola, Marco Confalonieri et al. · The Journal of Heart and Lung Transplantation · 2016 · 130 citations · Full text

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +10

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19

Miriana d’Alessandro, Paolo Cameli, Rosa Metella Refini et al. · Journal of Medical Virology · 2020 · 99 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Viral Diagnostics +15